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1. Introduction 
During experiments designed to test the stability of 
enzymes to a number of reagents [1], it was shown 
that triosephosphate d hydrogenase and glutamic dehy- 
drogenase became unstable in the presence of salicylate 
at a wide variety of concentrations and conditions, in- 
cluding therapeutic, and at physiological pH and tem- 
peratures [2]. We made the chance observation that 
triosephosphate and glutamic dehydrogenases were 
readily inactivated in control tubes wheff imidazole 
served as buffer. Although inhibition of alcohol dehy- 
drogenase by imidazole has previously been noted [3], 
we are unaware of any study reporting inactivation of 
enzymes by this reagent. Indeed, imidazole had been 
used extensively as an innocuous buffer. Since imida- 
zole is an efficient metal binding agent, we checked the 
possibility that there was a correlation between enzyme 
stability to salicylate, a good metal chelator [4], and 
metal requirements [5]. A comparison of stability to 
salicylate and imidazole of a number of enzymes i
presented here; the data indicate a close relationship 
between stability to these reagents and metal require- 
ments. 
2. Materials and methods 
Sodium salicylate was obtained from Fisher Scien- 
tific Company; imidazole, pig heart malic dehydroge- 
nase, bovine liver glutamic dehydrogenase, urease 
(Type V), ribonuclease, phosphoenol pyruvate carboxy- 
lase and Gum Carrageenin were obtained from Sigma. 
Methylsalicylic acid, 3-tert.butyl-6-methylsalicylic acid, 
p-hydroxybenzoic a id and meta-hydroxybenzoic acid 
were obtained from Aldrich Chemical Co. Enolase, 3- 
phosphoglycerate mutase (muscle and yeast) and acyl 
phosphatase were prepared as previously described 
[6-8].  All other reagents were commercial reagents. 
Female Sprague-Dawley rats, weighing 150-200 g 
were used for these studies. Standard assays were em- 
ployed in measuring triosephosphate d hydrogenase 
[9], glutamic hydrogenase [ 10], alcohol dehydroge- 
nase [ 11 ], malic dehydrogenase [ 12], phosphoenol 
pyruvate carboxylase [13], acyl phosphatase [8], 
urease [14], ribonuclease [ 15], enolase and mutase 
[7] activities. Proteins were determined by a modi- 
fication of the biuret method [16]. Rats were fed 
standard Purina Rat Chow to which imidazole or so- 
dium salicylate were added to give 1% concentrations. 
To produce paw edema in the rat, 0.1 ml of a 0.5% 
solution of Gum Carrageenin was injected subcutane- 
ously in the dorsum of a hind foot of lightly anesthe- 
tized (ether) animals which had been on one of the 
previously described iets for 6 -8  days. The degree 
of swelling and redness was compared 30 min after 
injection. These studies were conducted in collabora- 
tion with Dr.D.Scarpelli. 
The effects of imidazole and salicylate upon col- 
lagen-induced platelet aggregation [ 17] were carried 
out by Dr.J.Davis 
3. Results and discussion 
As illustrated in table 1, some enzymes are stable 
while others are not in the presence of salicylate or 
imidazole. Moreover, as shown, the effect of salicy- 
late on stability parallels that of imidazole. In an ef- 
fort to clarify these effects, we compared metal 
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Table 1 
Effect of imidazole and salicylate on stability of various enzymes. 
November 1970 
Enzyme tested 
% Remaining activity after 60 
min in the presences of 
Imiadazole Salicylate 
Metal requirement 
Malic dehydrogenase 22 0 + 
Enolase 1 0 + 
Phosphoenol pyruvate carboxylase 0 0 + 
Alcohol dehydrogenase 21 4 + 
Triosephosphate d hydrogenase 27 3 + 
Glutamic dehydrogenase 29 9 + 
Muscle P-glycerate mutase 100 100 - 
Yeast P-glycerate mutase 100 100 - 
Ribonuclease 100 100 - 
Acyl phosphatase 100 100 - 
Urease 100 100 - 
The incubation mixtures contained in 1 ml 20 vmoles of tris-Cl buffer, pH 7.0, when testing for stability of triosephosphate d hy- 
drogenase; 200 t~moles of KPO4 buffer, pH 7.5, when testing for stability of glutamic dehydrogenase; 200 vmoles of KPO4 buffer, 
pH 7.0, when testing for stability of urease; and 200 vmoles of tris-Cl buffer, pH 7.0, when testing for stability of all other enzymes. 
The following amounts of enzyme were added: 1.0 nag of rabbit muscle triosephosphate d hydrogenase, 1.0 mg of bovine fiver glu- 
tamic dehydrogenase, 0.1 mg of horse fiver alcohol dehydrogenase, 2.4 mg of phosphoenol pyruvate carboxylase, 0.1 mg of heart 
acyl phosphatase, 1.0 mg of urease, 0.2 mg of ribonuclease, 0.48 vU. of pig heart malic dehydrogenase, 100 units of enolase, 100 
units 6 of chicken or yeast P-glycerate mutase. When used, 400 vmoles of either imidazole or salicylate were added. Incubation was 
at 38 °. At zero time and at 60 rain, 5 - l0  ul aliquots were removed and assayed by the procedures referred to (see Methods). The 
controls remained entirely stable during the incubation. The activity at zero time was unchanged by the imidazole or saficylate used. 
requirements, SH and subunit composit ion for the en- 
zymes tested. These was no correlat ion between stabi- 
l ity and SH composit ion or subunits but, as shown in 
table 1, there seems to be an excel lent correlation be- 
tween instabil ity induced by both imidazole and salicy- 
late and metal  requirement [5].  For  compactness o f  
presentation, only data for a high concentra.tion of  
salicylate and imidazole are shown. However,  both 
imidazole and salicylate are effective also at lower con- 
centrations as i l lustrated with two dehydrogenases in 
fig. 1. 
It is o f  interest that p- and m-hydrobenzoic  acid do 
not appreciably inactivate tr iosephosphate or glutamic 
dehydrogenases. This is i l lustrated in table 2 and 3. 
In view o f  the above results, we tested the possi- 
bil ity that there was correlat ion between imidazole 
and salicylate ffects in other biological systems. Rats 
were fed imidazole or salicylate in their diets for 5 
days. The inf lammatory response produced by 0.5% 
Gum Carrageenin was reduced in the groups o f  rats 
fed imidazole and paralleled the response obtained 
lO0 
c 
E: 
-0  
umoles Salicylate o~ Imidazole added 
Fig. 1. The effect of imidazole and salicylate concentrations on
enzyme stability. • =, glutamic dehydrogenase plus salicylate; 
o---% triosephosphate plus salicylate; • •, glutamic dehydro- 
genase plus imidazole; • e, triosephosphate plus imidazole. 
Details are given in legend to table 1. 
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Table 2 
The effect of salicylate and related compounds on stability of glutamic dehydrogenase. 
November 1970 
Compound ~noles added 
% remaining activity at (hr) 
2 4 24 
Sodium salieylate 10 100 100 80 
Acetylsalicylate 10 100 100 80 
5-Methylsalicylate 10 90 90 80 
3-tert-Butyl-6-methylsalicylate 10 15 0 
Sodium salicylate 20 100 100 70 
Acetylsalicylate 20 100 100 70 
5-Methylsalieylate 20 80 80 60 
3-tert-Butyl-6-methylsalicylate 20 10 0 
Sodium salicylate 50 90 80 50 
Acetylsalicylate 50 90 80 50 
5-Methylsalicylate 50 60 50 25 
3-tert-Butyl-6-methylsalicylate 50 10 0 
p-Hydroxybenzoate 50 90 90 90 
m-Hydroxybenzoate 50 100 100 100 
Benzoate 50 90 90 90 
The conditions were as given in legend to table 1 except hat the above compounds were added as indicated and the incubations 
were at 40 ° . 
Table 3 
The effect of salicylate and related compounds on stability of 
triosephosphate dehydrogenase. 
% Activity remaining at 1 hr 
#moles added 
10 20 30 40 50 
Sodium salicylate 78 63 27 25 23 
Acetylsalicylate 80 66 38 34 22 
5-Methylsalicylate 63 48 25 24 23 
3-tert-Butyl-6- 26 23 23 20 15 
methylsalicylate 
p-Hydroxybenzoate 92 81 77 68 
m-Hydroxybenzoate 97 85 84 73 
Benzoate 100 100 90 81 
Experimetal conditions axe as given in legend to tables 1 and 2. 
with animals fed salicylate. The salicylate and imida- 
zole treated animals howed minimal signs of  redness, 
or swelling in contrast o control animals. Moreover, 
imidazole at 1 and 5 mM concentrations in 0.9% NaC1 
produced 51 and 58% inhibition respectively of col- 
lagen induced platelet aggregation with 0.9% NaCI as 
control. Sodium salicylate at the same concentrations 
produced 11 and 47% inhibition respectively. 
The possibility that salicylates act therapeutically 
by forming chelates was considered many years ago 
[14]. Indeed, salicylate forms stable chelates with 
transition elements uch as cobalt, iron and copper 
with binding constants of  l0  s to 10 9 . The meta and 
para isomers of  hydroxy-benzoic a id, which do not 
form chelates, are ineffective both as antiinflamma- 
tory and as antipyretic agents. As shown here the 
same appears to apply to in vitro stability to salicy- 
late. According to Schubert and Lindenbaum [ 18], 
calcium and magnesium are not involved in salicylate 
action because they cannot displace the proton of 
the hydroxyl group of  salicylate and because the bin- 
ding constants are low; they suggested the participation 
of copper in salicylate action. It should be noted that 
predictions from binding constants [ 19] cannot be 
related to chelation in rive or in vitro [20]. Whether 
the effects found with salicylate and imidazole are 
common or characteristic of all metalloproteins eces- 
sitates additional studies. However, in all cases tested, 
if  one adds metals to the enzyme preparation the in- 
stability induced by salicylate and imidazole is pre- 
vented. In this context he investigation to find out 
if a number of metals, particularly zinc, as well as 
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other heavy metals both in animals and in patients 
which had received large amounts of  salicylate should 
be of  much interest. The effects upon several enzymes 
of feeding imidazole or salicylate to rats and rabbits 
are under study; it is too early to assess the observed 
changes and particularly whether or not we are dealing 
with effects on protein synthesis, degradation or both. 
Experiments are underway to correlate protein turn- 
over and enzyme inactivation. With the enzymes tested 
thus far imidazole is in all cases more effective than 
salicylate which may reflect non-specific binding pheno- 
mena rather than more selective binding due to chela- 
tion. Possibly we may be simply dealing with subunit 
association since subunits may be held together by 
heavy metals. 
The present findings are both of practical and 
theoretical interest, and may lead to a rational expla- 
nation of  the phenomonological aspects of  salicylate 
action. Such information may provide the basis for a 
better understanding and treatment of  diseases uch 
as rheumatic fever or rheumatoid arthritis. Possibly 
reagents uch as imidazole or derivatives thereof 
which may have less untoward effects than salicy- 
lates may prove to be useful in medicine. 
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